Bio-Gate AG Statistics
Total Valuation
Bio-Gate AG has a market cap or net worth of EUR 8.22 million. The enterprise value is 7.81 million.
Market Cap | 8.22M |
Enterprise Value | 7.81M |
Important Dates
The last earnings date was Monday, September 9, 2024.
Earnings Date | Sep 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Bio-Gate AG has 9.24 million shares outstanding.
Shares Outstanding | 9.24M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +3.14% |
Owned by Insiders (%) | 3.41% |
Owned by Institutions (%) | 2.00% |
Float | 2.00M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.90 |
EV / Sales | 1.03 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -6.82 |
Financial Position
The company has a current ratio of 2.59
Current Ratio | 2.59 |
Quick Ratio | 0.87 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -33.77 |
Financial Efficiency
Return on equity (ROE) is -68.91% and return on invested capital (ROIC) is -39.06%.
Return on Equity (ROE) | -68.91% |
Return on Assets (ROA) | -25.84% |
Return on Capital (ROIC) | -39.06% |
Revenue Per Employee | 180,283 |
Profits Per Employee | -47,691 |
Employee Count | 42 |
Asset Turnover | 1.59 |
Inventory Turnover | 2.26 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.11% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -1.11% |
50-Day Moving Average | 0.94 |
200-Day Moving Average | 1.00 |
Relative Strength Index (RSI) | 46.71 |
Average Volume (20 Days) | 150 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bio-Gate AG had revenue of EUR 7.57 million and -2.00 million in losses.
Revenue | 7.57M |
Gross Profit | 3.82M |
Operating Income | -1.97M |
Pretax Income | -2.03M |
Net Income | -2.00M |
EBITDA | -1.72M |
EBIT | -1.97M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
Cash & Cash Equivalents | 475,997 |
Total Debt | n/a |
Net Cash | 475,997 |
Net Cash Per Share | 0.05 |
Equity (Book Value) | 2.35M |
Book Value Per Share | n/a |
Working Capital | 1.54M |
Cash Flow
In the last 12 months, operating cash flow was -1.03 million and capital expenditures -115,000, giving a free cash flow of -1.15 million.
Operating Cash Flow | -1.03M |
Capital Expenditures | -115,000 |
Free Cash Flow | -1.15M |
FCF Per Share | -0.12 |
Margins
Gross margin is 50.42%, with operating and profit margins of -26.02% and -26.45%.
Gross Margin | 50.42% |
Operating Margin | -26.02% |
Pretax Margin | -26.81% |
Profit Margin | -26.45% |
EBITDA Margin | -22.76% |
EBIT Margin | -26.02% |
FCF Margin | -15.12% |
Dividends & Yields
Bio-Gate AG does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | n/a |
FCF Yield | -13.92% |
Stock Splits
The last stock split was on November 26, 2012. It was a reverse split with a ratio of 0.25.
Last Split Date | Nov 26, 2012 |
Split Type | Reverse |
Split Ratio | 0.25 |